Human Pathology
Volume 41, Issue 10 , Pages 1486-1494 , October 2010

The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasms

  • David M. Dorfman, MD, PhD

      Affiliations

    • Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA
    • Department of Pathology, Harvard Medical School, Boston, MA 02115, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • Jason L. Hornick, MD, PhD

      Affiliations

    • Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA
    • Department of Pathology, Harvard Medical School, Boston, MA 02115, USA
    • ,
  • Aliakbar Shahsafaei, MS

      Affiliations

    • Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA
    • Department of Pathology, Harvard Medical School, Boston, MA 02115, USA
    • ,
  • Gordon J. Freeman, PhD

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA
    • Department of Medicine, Harvard Medical School, Boston, MA 02115, USA

Received 9 December 2009 ,Revised 1 April 2010 ,Accepted 2 April 2010.

References 

  1. Rodriguez-Manzanet R, DeKruyff R, Kuchroo VK, Umetsu DT. The costimulatory role of TIM molecules. Immunol Rev. 2009;229:259–270
  2. Kobayashi N, Karisola P, Pena-Cruz V, et al. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity. 2007;27:927–940
  3. Golden-Mason L, Palmer BE, Kassam N, et al. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+T cells. J Virol. 2009;83(18):9122–9130
  4. Nakayama M, AKiba H, Takeda K, et al. Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood. 2009;113:3821–3830
  5. DeKruyff RH, Bu X, Ballesteros A, et al. TIM-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells. J Immunol. 2010;184:1918–1930
  6. Anderson AC, Anderson DE, Bregoli L, et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science. 2007;318(5853):1141–1143
  7. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008;
  8. Dorfman DM, Greisman HA, Shahsafaei A. Loss of expression of the WNT/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor (TCF-1) in a subset of peripheral T cell lymphomas. Am J Pathol. 2003;162:1539–1544
  9. Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ. Programmed death-1 (PD-1) is a marker of germinal center-associated T cell and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2006;30:802–810
  10. Weitzman S, Jaffe R. Uncommon histiocytic disorders: the non-Langerhans cell histiocytoses. Pediatr Blood Cancer. 2005;45:256–264
  11. Mills JA, Gonzalez G, Jaffe R. Case records of the Massachusetts General Hospital (Case 25-2008: a 43-year-old man with fatigue and lesion sin the pituitary and cerebellum. N Engl J Med. 2008;359:736–747
  12. Munoz-Fernandez R, Blanco FJ, Frecha C, et al. Follicular dendritic cells are related to bone marrow stromal cell progenitors and to myofibroblasts. J Immunol. 2006;177:280–289
  13. Lau SK, Chu PG, Weiss LM. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol. 2008;32:615–619
  14. Hornick JL, Jaffe ES, Fletcher CDM. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol. 2004;28:1133–1144
  15. Yu H, Gibson JA, Pinkus GS, Hornick JL. Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors. Am J Clin Pathol. 2007;128:776–782
  16. Hastings WD, Anderson DE, Kassam N, et al. TIM-3 is expressed on activated human CD4+T cells and regulates TH1 and TH17 cytokines. Eur J Immunol. 2009;39(9):2492–2501
  17. Montecino-Rodriguez E, Leathers H, Dorshkind K. Bipotential B-macrophage progenitors are present in adult bone marrow. Nat Immunol. 2001;2:83–88
  18. Hou YH, Srour EF, Ramsey H, Dahl R, Broxmeyer HE, Hromas R. Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4. Blood. 2005;105:3488–3492
  19. Feldman AL, Arber DA, Pittaluga S, et al. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood. 2008;111:5433–5439
  20. Feldman AL, Minniti C, Santi M, Downing JR, Raffeld M, Jaffe ES. Histiocytic sarcoma after acute lymphoblastic leukemia: a common clonal origin. Lancet Oncol. 2004;5:248–250
  21. Magni M, Di Nicola M, Carlo-Stella C, et al. Identical gene rearrangement of immunoglobulin heavy chain gene in neoplastic Langerhans cells and B-lymphocytes: evidence for a common precursor. Leuk Res. 2002;26:1131–1133
  22. Xie H, Ye M, Feng R, Graf T. Stepwise reprogramming of B cell into macrophages. Cell. 2004;117:663–676
  23. Colbaleda C, Jochum W, Busslinger M. Conversion of mature B cells into T cell by dedifferentiation to uncommitted progenitors. Nature. 2007;449:473–477
  24. Paquette RL, Hsu N, Said J, et al. Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo. Leukemia. 2002;16:1484–1489
  25. Marafioti T, Ascani S, Pulford K, et al. Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. Am J Pathol. 2003;162:861–871
  26. Dorfman DM, Hwang ES, Shahsafaei A, Glimcher LH. T-bet, a T-cell-associated transcription factor, is expressed in a subset of B-cell lymphoproliferative disorders. Am J Clin Pathol. 2004;122:292–297

PII: S0046-8177(10)00121-8

doi: 10.1016/j.humpath.2010.04.005

Human Pathology
Volume 41, Issue 10 , Pages 1486-1494 , October 2010

Article Tools

* Image Usage & Resolution